Bellevue Group’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-24,015
Closed -$469K 166
2024
Q3
$469K Sell
24,015
-1,125,142
-98% -$22M 0.01% 130
2024
Q2
$19.7M Sell
1,149,157
-5,475
-0.5% -$93.7K 0.32% 74
2024
Q1
$19.4M Buy
1,154,632
+23,521
+2% +$395K 0.3% 78
2023
Q4
$20.4M Sell
1,131,111
-671,852
-37% -$12.1M 0.31% 74
2023
Q3
$30.6M Sell
1,802,963
-2,620
-0.1% -$44.4K 0.49% 57
2023
Q2
$21.7M Sell
1,805,583
-21,387
-1% -$257K 0.31% 72
2023
Q1
$23.8M Buy
1,826,970
+46,826
+3% +$610K 0.35% 72
2022
Q4
$28.4M Buy
1,780,144
+22,069
+1% +$352K 0.38% 72
2022
Q3
$15.9M Buy
1,758,075
+1,768
+0.1% +$16K 0.23% 92
2022
Q2
$21.4M Buy
1,756,307
+5,617
+0.3% +$68.3K 0.3% 84
2022
Q1
$33.1M Buy
1,750,690
+673,820
+63% +$12.7M 0.38% 79
2021
Q4
$37.8M Buy
1,076,870
+70,723
+7% +$2.48M 0.39% 77
2021
Q3
$36.8M Buy
1,006,147
+141,387
+16% +$5.18M 0.37% 82
2021
Q2
$34M Sell
864,760
-110,728
-11% -$4.35M 0.33% 89
2021
Q1
$27.6M Buy
975,488
+27,814
+3% +$786K 0.29% 92
2020
Q4
$30.3M Hold
947,674
0.35% 79
2020
Q3
$30.6M Hold
947,674
0.42% 66
2020
Q2
$26.1M Buy
947,674
+95,680
+11% +$2.64M 0.37% 68
2020
Q1
$15.2M Buy
851,994
+34,177
+4% +$610K 0.29% 69
2019
Q4
$20.5M Buy
817,817
+29,619
+4% +$743K 0.33% 59
2019
Q3
$13.8M Buy
788,198
+189,888
+32% +$3.32M 0.26% 72
2019
Q2
$13.2M Hold
598,310
0.22% 73
2019
Q1
$18.3M Buy
598,310
+158,141
+36% +$4.84M 1.01% 30
2018
Q4
$10.2M Buy
440,169
+40,140
+10% +$927K 0.67% 43
2018
Q3
$12.9M Buy
400,029
+67,493
+20% +$2.17M 0.82% 43
2018
Q2
$10M Buy
332,536
+30,116
+10% +$908K 0.85% 45
2018
Q1
$8.94M Buy
302,420
+168,570
+126% +$4.98M 0.89% 44
2017
Q4
$5.26M Buy
133,850
+69,277
+107% +$2.72M 0.55% 47
2017
Q3
$1.75M Buy
64,573
+35,331
+121% +$958K 0.18% 86
2017
Q2
$682K Buy
+29,242
New +$682K 0.08% 120